260 views
$AKBA is a heavily shorted bio-technology company that recently won DOD funding for one of their phase three candidates. I think the bullish trend is just getting started and a real shove will add 100% or more to the price of the stock.
All ideas are based on my own research. As always I recommend you take the time to do diligence on your investments to make sure they match your risk and objectives.
Comments